The central terminations, in the trigeminal nucleus, of afferents from the rat's postero-orbital (PO) sinus hair have been investigated with transganglionic transport of horseradish peroxidase (HRP) and succinic dehydrogenase (SDH) histochemistry. The normal pattern of terminations has been compared with that found after section of an adjacent nerve, the infraorbital (IO) nerve, at three ages: neonatal, 1 week old, and adult. The PO afferent fibres have three separate representations in the brainstem--in trigeminal sensory nucleus principalis (Vp) and rostral subnucleus oralis (Vo), in trigeminal subnucleus interpolaris (Vi), and in caudal trigeminal subnucleus caudalis (Vc) and C1 dorsal horn. In coronal sections the areas of terminations were seen as oval patches lying ventrolaterally in Vp, Vo, and Vi and ventromedially in Vc and C1. Following neonatal IO nerve section the terminal areas were approximately doubled in Vp, Vo, and Vi but were unchanged in Vc and C1. IO nerve section at day 7 also caused a significant, though smaller (1.4x compared with 2.0x), increase in the terminal areas in the rostral three nuclei, without changing Vc and C1. However, no significant change in area occurred after adult IO nerve section. SDH histochemistry at 3 to 4 weeks of age showed patches of terminals on both normal and lesioned sides consistent with those seen after HRP. Previous studies have reported increased functional representation of surrounding intact skin regions, including the PO sinus hairs, after neonatal but not adult, IO nerve section. The present results show that there are concomitant anatomical changes. Like the functional results, the extent of the anatomical changes are dependent on the maturity of the rat when lesioned.
The morphology and innervation of the postero-orbital (PO) sinus hair has been studied in normal rats and in adult animals in which an adjacent nerve, the infraorbital nerve, was sectioned on postnatal day 0 or day 7. The normal morphology of the follicle was similar to that of mystacial sinus hairs. However, the normal innervation differed from mystacial follicles in three respects: (1) instead of a separate innervation, the deep vibrissal nerve (DVN) and dermal plexus were supplied by a common follicle and skin nerve, named here the postero-orbital cutaneous nerve, a branch of the zygomaticofacial nerve; (2) the entry of the DVN through the capsule was highly variable; in some cases fascicles entered in close proximity, but in others they were widely distributed around the capsule; and (3) two or three small nerves, called here anastomosing nerves, were found to leave the PO follicle. These arose from the DVN after it had passed through the capsule to the cavernous sinus. The anastomosing nerves passed back through the capsule and ascended on the outer surface of the follicle to join the dermal plexus. Each nerve contained 1-4 myelinated fibres and 11-35 unmyelinated fibres. Infraorbital (IO) nerve section on day 0 caused a 19% (P less than 0.001, n = 8) increase in numbers of fibers to the DVN on the lesioned side. Most of the increase was due to unmyelinated fibres with no significant change in myelinated axons. No change in axon numbers in the DVN occurred after day 7 lesions. Labelling of the mystacial pad and the PO follicle did not result in any double labelling of cells in the trigeminal ganglion, in either normal or lesioned animals, making it improbable that the increased numbers of unmyelinated axons arose from rerouting of infraorbital fibres. It is suggested that the increased innervation of the PO follicle may arise by the rescue of ganglion cells from developmentally programmed cell death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.